Kalaris Therapeutics, Inc. (KLRS) 52-week high is $24.15
Kalaris Therapeutics, Inc. (KLRS) 52-week high is $24.15. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full KLRS research page for quote, filings, and the rest of the model. This satellite exists so “Kalaris Therapeutics, Inc. 52-week high” can rank with the actual number, then send you to /stock/klrs.